220 related articles for article (PubMed ID: 22294641)
1. Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial.
Spaeth M; Bennett RM; Benson BA; Wang YG; Lai C; Choy EH
Ann Rheum Dis; 2012 Jun; 71(6):935-42. PubMed ID: 22294641
[TBL] [Abstract][Full Text] [Related]
2. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study.
Russell JI; Holman AJ; Swick TJ; Alvarez-Horine S; Wang GY; Guinta D;
Pain; 2011 May; 152(5):1007-1017. PubMed ID: 21397402
[TBL] [Abstract][Full Text] [Related]
3. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
Russell IJ; Perkins AT; Michalek JE;
Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896
[TBL] [Abstract][Full Text] [Related]
4. Sodium oxybate for the treatment of fibromyalgia.
Staud R
Expert Opin Pharmacother; 2011 Aug; 12(11):1789-98. PubMed ID: 21679091
[TBL] [Abstract][Full Text] [Related]
5. Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia.
Spaeth M; Alegre C; Perrot S; Wang Y; Guinta DR; Alvarez-Horine S; Russell I;
Arthritis Res Ther; 2013 Nov; 15(6):R185. PubMed ID: 24286114
[TBL] [Abstract][Full Text] [Related]
6. Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
Arnold LM; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
Arthritis Res Ther; 2011 Jun; 13(3):R86. PubMed ID: 21668963
[TBL] [Abstract][Full Text] [Related]
7. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.
Scharf MB; Baumann M; Berkowitz DV
J Rheumatol; 2003 May; 30(5):1070-4. PubMed ID: 12734908
[TBL] [Abstract][Full Text] [Related]
8. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
J Clin Sleep Med; 2010 Dec; 6(6):596-602. PubMed ID: 21206549
[TBL] [Abstract][Full Text] [Related]
9. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study.
Moldofsky H; Inhaber NH; Guinta DR; Alvarez-Horine SB
J Rheumatol; 2010 Oct; 37(10):2156-66. PubMed ID: 20682669
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the narcoleptiform sleep disorder in chronic fatigue syndrome and fibromyalgia with sodium oxybate.
Spitzer AR; Broadman M
Pain Pract; 2010; 10(1):54-9. PubMed ID: 20629967
[TBL] [Abstract][Full Text] [Related]
11. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
Ondo WG; Perkins T; Swick T; Hull KL; Jimenez JE; Garris TS; Pardi D
Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348
[TBL] [Abstract][Full Text] [Related]
12. Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial.
Roth T; Dauvilliers Y; Thorpy MJ; Kushida C; Corser BC; Bogan R; Rosenberg R; Dubow J; Seiden D
CNS Drugs; 2022 Apr; 36(4):377-387. PubMed ID: 35380374
[TBL] [Abstract][Full Text] [Related]
13. A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.
George CF; Feldman N; Zheng Y; Steininger TL; Grzeschik SM; Lai C; Inhaber N
Sleep Breath; 2011 Jan; 15(1):13-20. PubMed ID: 20082240
[TBL] [Abstract][Full Text] [Related]
14. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
Black J; Swick T; Bogan R; Lai C; Carter LP
Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
[TBL] [Abstract][Full Text] [Related]
15. Mirtazapine for fibromyalgia in adults.
Welsch P; Bernardy K; Derry S; Moore RA; Häuser W
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012708. PubMed ID: 30080242
[TBL] [Abstract][Full Text] [Related]
16. Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.
Kushida CA; Shapiro CM; Roth T; Thorpy MJ; Corser BC; Ajayi AO; Rosenberg R; Roy A; Seiden D; Dubow J; Dauvilliers Y
Sleep; 2022 Jun; 45(6):. PubMed ID: 34358324
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia.
Ohta H; Oka H; Usui C; Ohkura M; Suzuki M; Nishioka K
Arthritis Res Ther; 2012 Oct; 14(5):R217. PubMed ID: 23062189
[TBL] [Abstract][Full Text] [Related]
18. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
[TBL] [Abstract][Full Text] [Related]
19. Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsy.
Husain AM; Bujanover S; Ryan R; Scheckner B; Black J; Profant J
J Clin Sleep Med; 2020 Sep; 16(9):1469-1474. PubMed ID: 32356515
[TBL] [Abstract][Full Text] [Related]
20. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
Büchele F; Hackius M; Schreglmann SR; Omlor W; Werth E; Maric A; Imbach LL; Hägele-Link S; Waldvogel D; Baumann CR
JAMA Neurol; 2018 Jan; 75(1):114-118. PubMed ID: 29114733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
